# Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer

> **NCT03848182** · PHASE2 · TERMINATED · sponsor: **Albert Einstein College of Medicine** · enrollment: 10 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Gemcitabine
- **BIOLOGICAL:** TT vaccine booster

## Key facts

- **NCT ID:** NCT03848182
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-07-21
- **Primary completion:** 2018-11-23
- **Final completion:** 2019-11-11
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2024-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03848182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03848182, "Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03848182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*